References
Briggs A, Shiell A. Interferon-α in hepatitis C: dosage, costs and benefits. Pharmacoeconomics 1996; 10(3): 205–9
Nishiguchi S, Kuroki T, Morimoto H, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051–55
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koff, R.S. Interferon-α in Hepatitis C. PharmacoEconomics 11, 491 (1997). https://doi.org/10.2165/00019053-199711050-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199711050-00010